17Β-Estradiol Potentiates Ischemia–reperfusion Injury in Diabetic Ovariectomized Female Rats

Y Yong,HJ Xie,YF Zhang,QD Yang,DF Liao,HL Yang,PK Yan,ZJ Liu
DOI: https://doi.org/10.1016/j.brainres.2005.05.069
IF: 3.61
2005-01-01
Brain Research
Abstract:To investigate the effect of 17 beta-estradiol (E-2) on ischemia-reperfusion (I/R) injury in diabetic ovariectomized female rats. Streptozotocin(STZ)-induced diabetic female rats received E-2 treatment for 2 weeks after ovariectomy (OVX). A period of 90 min of temporary middle cerebral artery occlusion (tMCAO) was used for the study. Rats were evaluated for physiological data including plasma glucose, E-2, MAP, PaCO2 and PaO2 before and after tMCAO. P-selectin expression, myeloperoxidase (MPO) enzyme activity and the cerebral infarct volume were analyzed. The infarct volume in the E-2-treated OVX rats is bigger than that in intact and OVX groups. However, there is not a significant different area of cerebral infarct between diabetic OVX and intact rats. Significant upregulation of P-selectin expression and MPO activity of the ischemia-reperfusion hemisphere were observed in E-2 + OVX, intact and OVX groups at 8, 24, 72 h in time manner after tMCAO compared with that of the contralateral hemisphere of cerebral ischemia-reperfusion. Both P-selectin expression and MPO activity in the E-2 + OVX and intact rats are significantly higher than that in the untreated OVX rats. Chronic estrogen replacement therapy (ERT) potentiates the I/R injury in diabetes female rats. This may be related to the increased expression of P-selectin and MPO activity. (c) 2005 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?